PGNY Share Price Performance
US$23.49
2.64 (12.66%)
30.1% undervalued intrinsic discount
US$33.59
Fair Value
Price US$23.49
AnalystHighTarget US$33.59
AnalystConsensusTarget US$26.75
AnalystLowTarget US$23.00
Fair ValueUS$33.59
Share PriceUS$23.49
30.1% undervalued intrinsic discount
PGNY Community Narratives
AN
Fair Value US$33.59 30.1% undervalued intrinsic discount
Rising Maternal Age And Digital Health Will Expand Markets
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value US$26.75 12.2% undervalued intrinsic discount
Investments In BenefitBump And Digital Assets Will Improve Service Offerings And Member Engagement
0users have liked this narrative
0users have commented on this narrative
23users have followed this narrative
AN
Fair Value US$23.00 2.1% overvalued intrinsic discount
Amazon Exit And Fierce Competition Will Dampen Prospects
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Recent PGNY News & Updates
No updates
Progyny, Inc. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 07, 2025
- Earnings per share (EPS)
- 0.61
- Gross Margin
- 21.99%
- Net Profit Margin
- 4.33%
- Debt/Equity Ratio
- 0%
Progyny, Inc. Competitors
About PGNY
- Founded
- 2008
- Employees
- 678
- CEO
- WebsiteView website
Progyny, Inc., a benefits management company, provides fertility, family building, and women’s health benefits solutions in the United States. The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services. In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
U.S. Market Performance
- 7 Days: -1.2%
- 3 Months: 12.3%
- 1 Year: 21.3%
- Year to Date: 7.0%
In the last week, the market has fallen 1.2%, dragged down most by the Consumer Discretionary. In contrast to the last week, the market is actually up 21% over the past year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading